Q2 2026 13F filing
Updated 27 days ago277 disclosed positions worth $2.2B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AAVXF ABIVAX SA | $240.5M | 1.80M | 11.01% | — |
| 2 | P PB PROTAGONIST THERAPEUTICS INC | $117.8M | 960.9K | 5.39% | — |
| 3 | R ROIV ROIVANT SCIENCES LTD | $111.7M | 3.16M | 5.11% | — |
| 4 | S SPY STATE STR SPDR S&P 500 ETF T | $96.4M | 129.1K | 4.41% | — |
| 5 | I IMVT IMMUNOVANT INC | $89.8M | 2.33M | 4.11% | — |
| 6 | Z ZLAB ZAI LAB LTD | $64M | 3.37M | 2.93% | — |
| 7 | M MGRB AGIOS PHARMACEUTICALS INC | $47.8M | 1.29M | 2.19% | — |
| 8 | C CRNX CRINETICS PHARMACEUTICALS IN | $45.7M | 1.22M | 2.09% | — |
| 9 | ? N/A EA SERIES TRUST | $39.5M | 337.1K | 1.81% | — |
| 10 | C CYTK CYTOKINETICS INC | $39M | 457.9K | 1.79% | — |
| 11 | S SEPN SEPTERNA INC | $31.5M | 940.7K | 1.44% | — |
| 12 | A AVR ANTERIS TECHNOLOGIES GLOBAL | $31M | 3.15M | 1.42% | — |
| 13 | E EIX EDITAS MEDICINE INC | $28.8M | 8.89M | 1.32% | — |
| 14 | D DNLI DENALI THERAPEUTICS INC | $26.5M | 1.03M | 1.21% | — |
| 15 | S SYRE SPYRE THERAPEUTICS INC | $25.2M | 284.0K | 1.15% | — |
| 16 | V VIR VIR BIOTECHNOLOGY INC | $25M | 2.46M | 1.15% | — |
| 17 | P PRAX PRAXIS PRECISION MEDICINES I | $24.9M | 74.3K | 1.14% | — |
| 18 | I INSM INSMED INC | $24.4M | 228.5K | 1.11% | — |
| 19 | C CLDX CELLDEX THERAPEUTICS INC NEW | $23.1M | 619.5K | 1.05% | — |
| 20 | V VIK VIKING THERAPEUTICS INC | $22.4M | 574.0K | 1.02% | — |
| 21 | T TSHA TAYSHA GENE THERAPIES INC | $20.7M | 3.04M | 0.95% | — |
| 22 | M MNPR MONOPAR THERAPEUTICS INC | $20.1M | 217.6K | 0.92% | — |
| 23 | O OVID OVID THERAPEUTICS INC | $20M | 7.42M | 0.91% | — |
| 24 | E ELVN ENLIVEN THERAPEUTICS INC | $19.7M | 387.7K | 0.90% | — |
| 25 | E ENTA ENANTA PHARMACEUTICALS INC | $19.6M | 1.34M | 0.90% | — |
| 26 | E ETHA ISHARES TR | $18.8M | 62.5K | 0.86% | — |
| 27 | S SPY STATE STR SPDR S&P 500 ETF T | $18.7M | 25.0K | 0.85% | — |
| 28 | N NKTR NEKTAR THERAPEUTICS | $17M | 244.2K | 0.78% | — |
| 29 | I INSP INSPIRE MED SYS INC | $16.7M | 374.6K | 0.76% | — |
| 30 | R RVMDW REVOLUTION MEDICINES INC | $16.4M | 87.5K | 0.75% | — |
| 31 | E ESTA ESTABLISHMENT LABS HLDGS INC | $15.9M | 185.6K | 0.73% | — |
| 32 | P PRTA PROTHENA CORP PLC | $15.2M | 1.55M | 0.70% | — |
| 33 | R RYTM RHYTHM PHARMACEUTICALS INC | $15.1M | 136.2K | 0.69% | — |
| 34 | I IKT INHIBIKASE THERAPEUTICS INC | $15M | 7.39M | 0.69% | — |
| 35 | Q QURE UNIQURE NV | $15M | 324.7K | 0.68% | — |
| 36 | R RLYB RALLYBIO CORP | $14.8M | 926.4K | 0.68% | — |
| 37 | R REGN REGENERON PHARMACEUTICALS | $13.8M | 22.2K | 0.63% | — |
| 38 | I IVEVF INVENTIVA SA | $13.6M | 3.61M | 0.62% | — |
| 39 | ? N/A SUTRO BIOPHARMA INC | $13.4M | 404.0K | 0.61% | — |
| 40 | I IONS IONIS PHARMACEUTICALS INC | $13.2M | 166.3K | 0.60% | — |
| 41 | B BBIO BRIDGEBIO PHARMA INC | $13.2M | 176.7K | 0.60% | — |
| 42 | S SAY SAREPTA THERAPEUTICS INC | $13.1M | 730.6K | 0.60% | — |
| 43 | C CTMX CYTOMX THERAPEUTICS INC. | $12.6M | 3.37M | 0.58% | — |
| 44 | V VOR VOR BIOPHARMA INC | $12.5M | 680.6K | 0.57% | — |
| 45 | S STT-PG SPDR SERIES TRUST | $12.4M | 135.6K | 0.57% | — |
| 46 | ? N/A EQUILLIUM INC | $12M | 3.76M | 0.55% | — |
| 47 | A ANL ADLAI NORTYE LTD | $11.7M | 1.02M | 0.54% | — |
| 48 | ? N/A CLIMB BIO INC | $10.7M | 822.6K | 0.49% | — |
| 49 | S STT-PG SPDR SERIES TRUST | $10.7M | 67.4K | 0.49% | — |
| 50 | ? N/A HELIX ACQUISITION CORP III | $10.6M | 1.00M | 0.49% | — |